The CD68+ Macrophages to CD8+ T-Cell Ratio is Associated with Clinical Outcomes in Hepatocellular Carcinoma
Haibei Xin,Huan Chen,Hao Zhang,Shanshan Li,Zhang Minfeng,Guanghui Ding,Cunzhen Zhang,Zhiwen Ding,Lihong Wu,Wenbo Han,Wei Zhou,Yanhui Chen,Hongli Luo,Yating Wang,Henghui Zhang,Shupeng Liu,Nan Li
DOI: https://doi.org/10.2139/ssrn.3449326
2019-01-01
Abstract:Purpose: Tumor microenvironment plays pivotal roles in the development of tumors including hepatocellular carcinoma (HCC). As an important component of tumor microenvironment, tumor infiltrating immune cells (TILs) contribute to tumor development and relapse. However, whether TIL features are correlated with the prognosis of HCC patients remains unclear.Experimental Design: Cancer tissue and paired paracancerous tissues from 220 stage II HCC patients were collected. TILs including CD68+ macrophages and CD8+ T-cells were analyzed using a tyramide signal amplification system combined with immunohistochemistry. Kaplan-Meier survival analysis was performed to investigate the correlation between the prognosis and the infiltrating pattern of TILs in the cancer area (CA) or stroma area (SA) of tissues.Results: The patients were classified into three distinct subgroups (Clusters (C)1-3) with different overall survival (OS) and disease-free survival (DFS) according to the distribution pattern of TILs. The C1 group, characterized by the most CD68+ macrophages in the cancer SA and the fewest CD8+ T-cells in all tissues, displayed the poorest OS and DFS among the three groups. In addition, the CD68/CD8 ratio in the cancer SA was also correlated with the prognosis. Patients with a higher CD68/CD8 ratio exhibited poorer OS and DFS than those with a lower ratio. The CD68/CD8 ratio in the cancer SA was an independent predictor of OS but not DFS.Conclusion: CD68+ macrophages and CD8+ T-cells are essential immunological determinants for HCC prognosis, and the CD68/CD8 ratio in cancer SA is a novel, independent prognostic factor for OS in patients with resectable HCC.Funding Statement: This work was supported by The National Key Sci-Tech Special Project of China (No. 2018ZX10302204003, No. 2018ZX10302207), the grants of Shanghai Education Committee of Shuguang Plan (No. 18SG32); The National Key Basic Research Program “973 project” (No. 2015CB555400); and the National Natural Science Foundation of China (No. 81472282, No. 81672899). The UK Medical Research Council funded the TOBY-Xe study, and participating hospitals and The Centre for the Developing Brain, King's College London, UK, supported the follow-up study.Declaration of Interests: The authors declared no conflicts of interest.Ethics Approval Statement: This study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of Eastern Hepatobiliary Surgery Hospital.